InvestorBrandNetwork (IBN) Content Platform

FE Battery Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, is reporting the positive results of hydrometallurgical testwork at its Augustus Lithium Project. According to the announcement, the testing produced battery-grade lithium carbonate from pegmatite samples obtained from the project, which is adjacent to the North American Lithium mine in Quebec. FE Battery Metal worked with SGS Canada Inc. for the testwork, which evaluated, established and confirmed the optimal hydrometallurgical process flowsheet required to successfully extract high-purity lithium carbonate from previously developed spodumene concentrate produced from the Augustus Lithium Project. The world’s leading testing, inspection and certification company, SGS is widely recognized as establishing the global benchmark for sustainability, quality and integrity; the company has 99,600 employees and 2,600 offices and laboratories around the world. “SGS was pleased to support our client, FE Battery Metals Corp, in developing a hydrometallurgical flowsheet for extracting high-purity lithium carbonate, a crucial chemical in the battery supply chain,” said SGS North America vice president of natural resources Cordoba in the press release. “Our Lakefield team is committed to delivering innovation in extractive metallurgy while upholding our company’s strong commitment to sustainability.”

FE also announced the acquisition of 47 mineral claims in two claim blocks covering approximately 2,759.80 hectares of land in Québec. The company acquired the mining claims from an arm’s length seller. The company noted that infrastructure support, availability of water and power locally, and historically successful results make the claims a promising exploration target for rare earth metals and uranium.

To view the full press release, visit https://ibn.fm/ZDlaZ

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. The company’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FEBatteryMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

The upcoming 4th Chief Patient Officer Summit, hosted by Dynamic Global Events, will convene on July 15-16, 2024, in Boston, MA. Professionals in Patient Affairs, Clinical Trials, Patient Communications, Patient Advocacy, and related industry areas are invited to attend at the Hilton Boston Back Bay.

The summit, which will include panel presentations, two concurrent workshops, and networking opportunities, will gather top leaders from the healthcare industry to focus on patient engagement and…

Read More>>

For conference and registration details, visit www.dgevents.com/event/chief-patient-officer-summit/

*Use discount code IBN2024 to save 15% off*

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

In a landmark move signaling Canada’s firm commitment to space exploration, the government has thrown its support behind what is being called Canada’s version of Cape Canaveral. This endorsement comes at a time when the global demand for commercial space launches is reaching unprecedented levels. The Rude Awakening, a division of Paradigm Press headed up by former banker and financial educator Sean Ring, recently published an article titled “King: Canada’s Cape Canaveral North” that covers the momentum taking place in the space sector.

As pointed out by the article’s author Byron King, the decision to support investment in the construction of a spaceport underscores the Canadian government’s recognition of the economic and technological potential of the space sector. The Government of Canada is clearly keen to become a leading player in the rapidly evolving space industry, fostering innovation, job creation and international collaboration.

A notable development in this ambitious project is the involvement of Maritime Launch Services Ltd. (OTCQB: MAXQF), a Canadian-owned commercial space company based in Nova Scotia. The company recently entered an agreement with the Province of Nova Scotia and the Government of Canada that extends generous terms to reimburse the costs for various launch facilities.

The demand for commercial launch services has surged in recent years, driven by the proliferation of satellite technologies, the rise of private space companies and the increasing accessibility of space exploration. The Maritime Launch location, Spaceport Nova Scotia, offers unparalleled advantages for meeting this demand, with access to polar and sun synchronous orbits and minimal air and maritime traffic ensuring efficient and cost-effective access to space.

As the global space industry continues to evolve, Canada stands poised to play a central role in shaping its future. With the Canadian and provincial government’s support, coupled with the demand for commercial launch services and its strategic location, the construction of a new spaceport represents a bold step forward for Canada’s program and a testament to the nation’s commitment to commercial space and innovation.

To view the full article, visit https://ibn.fm/8FAZJ

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

EF Hutton has announced that it served as the sole underwriter to Plutonian (NASDAQ: PLTN), a special purpose acquisition company, in connection with its approximately $500 million completed business combination with Big Tree Cloud International Group Limited, a consumer-oriented company dedicated to the development, production and sales of personal care products and other consumer goods in China. The listed company following the business combination is Big Tree Cloud Holdings Limited (NASDAQ: DSY, DSYWW), and its shares and warrants have commenced trading on the Nasdaq under the tickers DSY and DSYWW, respectively.

For more information regarding the transaction, visit https://ibn.fm/RKsWb

About Plutonian Acquisition Corp.

Plutonian is a Delaware corporation incorporated as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Blue Hat (NASDAQ: BHAT) and Sichuan Jinyinghe Industrial Co. Ltd. announced the signing of a framework cooperation agreement to jointly establish a leading gold supply chain company. According to the announcement, the collaboration aims to integrate industrial resources and international financial capital to address various issues currently faced by the gold industry, promote transformation and innovation, and create a comprehensive, efficient gold supply chain ecosystem. “Collaborating with Jinyinghe, a company with many years of experience in gold trading and supply chain management, is another significant step following our acquisition of a Class A license as a precious metals and gemstone dealer from Hong Kong Customs,” said Blue Hat CEO Chen Xiaodong. “We will introduce international resources and work with Jinyinghe to open up gold circulation channels in relevant countries and regions, including but not limited to Southeast Asia and the Middle East. The successful operation of this project will enhance Blue Hat’s operational strength and market influence and provide an excellent platform and opportunity for participants in the gold business, effectively promoting the transformation of the gold industry.”

To view the full press release, visit https://ibn.fm/VyvgI

About Blue Hat Interactive Entertainment Technology

Blue Hat was formerly a provider of communication services and IDC business, as well as a producer, developer and operator of AR interactive entertainment games, toys and educational materials in China. Leveraging years of technological accumulation and unique patented technology, Blue Hat is expanding its business to commodity trading, aiming to become a leading intelligent commodity trader worldwide. For more information, please visit the company’s investor relations website at http://ir.bluehatgroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vivos Therapeutics (NASDAQ: VVOS) is a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders (including all severities of obstructive sleep apnea (“OSA”) in adults). The company today announced the execution of a strategic marketing and distribution alliance with an operator of multiple sleep testing and treatment centers in Colorado. Hoped to be the first in a series across the country, the alliance marks an important pivot in Vivos’ marketing and distribution model for its cutting edge OSA appliances. “We cannot overstate the importance of this alliance to Vivos and its future, coupled with a validating private equity-led investment from Seneca,” said Kirk Huntsman, chairman and CEO of Vivos. “Over the last several years, peer-reviewed studies have confirmed our longstanding belief that Vivos has the most effective, safe and potentially lasting non-surgical solution for all severities of OSA in adults that does not require lifelong nightly intervention. This was further validated by recent unprecedented FDA clearances Vivos has received, including the only FDA clearance for an oral medical device to treat severe OSA in adults.”

To view the full press release, visit https://ibn.fm/OFXn2

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to severe OSA in adults. It has proven effective in over 42,600 patients treated worldwide by more than 1,950 trained dentists. The Vivos Method includes treatment regimens that employ the proprietary CARE appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The three Vivos CARE devices open airway space and may significantly reduce symptoms and conditions associated with mild to severe OSA in adults, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using The Vivos Method. For more information, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Sustain SoCal invites state and regional leaders to discuss mobility policy, efforts towards EV charging infrastructure, incentives to go electric, cybersecurity considerations, V2X, hydrogen/fuel cell, investor trends, legislative updates, and other green modes of transport at Driving Mobility 11 on June 27th, 2024 in Irvine, CA.

Enjoy a discussion on best practices and new solutions followed by a clean…

Read More>>

To know more, please visit https://ibn.fm/yKMfu

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Diamond Lake Minerals (OTC: DLMI), a multistrategy operating company offering traditional investors an entry point to the future of digital securities, buying, investing and growing an innovative portfolio of companies and attaching digital securities to those businesses, has entered into a $3.75 million share exchange agreement with GlobexUS Holdings Corp. (Horizon Fintex). Horizon Fintex is the pioneering force powering the regulated tokenized-securities exchange Upstream. According to the agreement, Horizon Fintex issued 1,250 common shares, priced at $3,000 per share, in exchange for one million newly issued common shares in Diamond Lake Minerals. The share exchange partnership will benefit both parties by bringing new issuers to list on Upstream and increasing Upstream’s trading liquidity while also providing economic benefit to each company’s shareholders. In addition, Diamond Lake Minerals entered into a Cooperation, Marketing & Referral Agreement with a Horizon Fintex subsidiary as a commercial advisor to introduce and refer issuers seeking to list on Upstream. “When I took over DLMI in August of 2023, we set out to build what we believe will be the model of all future public companies, and I knew we could not accomplish that without international partners that know and understand securities laws, rules and regulations, and how we can properly and legally accomplish what we set out to do in the current regulatory frameworks,” said Diamond Lake Minerals CEO Brian J. Esposito in the press release. “We found all of that in Horizon Fintex, along with an impressive suite of blockchain technologies, and this partnership is yet another major milestone in the DLMI journey as we continue to build this great company, and strongly execute on our vision and plans.”

To view the full press release, visit https://ibn.fm/poCS6

About Diamond Lake Minerals Inc.

Diamond Lake Minerals was founded in 1954 and is a multistrategy operating company that specializes in the development and support of digital assets and SEC-registered security tokens. The company’s goal is to responsibly innovate and develop valuable traditional businesses and successfully combine those businesses with the future of money and digital assets. DLMI’s mission is to bring back to the public markets timeless business principles that are focused on healthy sustainable growth and strong earnings that generate yields combined in a modern digital world creating value for company stakeholders. DLMI is positioning itself as an industry agnostic leader in the digital asset and security token space. For more information, visit the company’s website at www.DiamondLakeMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Processa (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced positive efficacy results from the preliminary evaluation of its recently completed Phase 1b clinical trial. The trial defined the maximum tolerated dose (“MTD”) and recommended Phase 2 dose range (“RP2DR”) for Next Generation Capecitabine (“NGC-Cap”) administered to patients with stage III or IV gastrointestinal tract (“GI”) cancer. “We are encouraged by the preliminary efficacy analysis from our NGC-Cap Phase 1b dose-escalating safety/tolerability trial demonstrating some anti-tumor activity in patients with advanced GI cancer who have progressive cancer after relapsing or not responding to prior therapy. The favorable response is likely due to NGC-Cap’s ability to distribute more 5-FU to cancer cells than monotherapy capecitabine. The promising Phase 1b safety and tolerability profile plus these early efficacy signals provide validation for further development of NGC-Cap,” said David Young, PharmD, Ph.D., president of research and development at Processa. “From this Phase 1b trial, we have been able to define the MTD and the RP2DR to use in our Phase 2 Optimal Dosage Regimen trial in breast cancer in the third quarter of 2024.”

To view the full press release, visit https://ibn.fm/yp48Q

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing the Next Generation Chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining its novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach, as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will provide better therapy options to cancer patients but will also increase the probability of FDA approval for its NGC drugs following an efficient path to approval. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. The Processa team has a track record of obtaining over 30 indication approvals across almost every division of the FDA. Using its proven Regulatory Science Approach, the Processa Team has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGCs are expected to include fewer patients experiencing side effects that lead to dose discontinuation, more significant cancer response and a greater number of patients – in excess of 200,000 for each NGC drug – who will benefit from each NGC drug. Processa is currently 1) starting to initiate sites for the Phase 2 study that will identify the optimal dosage regimen for Next Generation Capecitabine (“PCS6422” and capecitabine to treat breast, metastatic colorectal, gastrointestinal, pancreatic and other cancers), 2) defining the design of the Next Generation Gemcitabine (“PCS3117” to treat pancreatic, biliary, lung, ovarian, breast and other cancers) Phase 2 optimal dosage regimen study to discuss with FDA, and 3) defining the formulation and toxicology program for Next Generation Irinotecan (“PCS11T” to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Predictive Oncology (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced the introduction of a new technology designed to express functional and stable G-Protein Coupled Receptors (“GPCRs”). GPCRs are cell surface membrane receptors believed to play a key role in tumorigenesis, with prior studies demonstrating involvement in cancer initiation, progression and metastasis. “As a result of our sustained efforts to develop this technology, Predictive Oncology has been able to file expansive intellectual property (‘IP’) protection for its novel GPCR expression platform,” said Dr. Larry DeLucas, SVP of biologics for Predictive Oncology. “We believe that this technology will open significant partnering opportunities for our company, and we look forward to working with drug discovery and development companies that are targeting GPCRs to expand their portfolios and replenish their pipelines.”

To view the full press release, visit https://ibn.fm/EX6GW

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Together with the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based drug discovery solutions, further complimented by its wholly owned CLIA lab and GMP facilities. Predictive Oncology is headquartered in Pittsburgh, Pennsylvania.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cybin (NYSE American: CYBN) (Cboe CA: CYBN) is a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options. The company today announced its appointment of Dr. Atul R. Mahableshwarkar M.D., DLFAPA, as its senior vice president, clinical development. Dr. Mahableshwarkar will lead the development of the CYB003 program, Cybin’s proprietary deuterated psilocybin analog that has received FDA Breakthrough Therapy Designation for the adjunctive treatment of major depressive disorder. “We are delighted to welcome Dr. Mahableshwarkar to the Cybin team at this critical juncture in the company’s progression,” said Amir Inamdar, chief medical officer of Cybin. “As we approach the initiation of our phase 3 study of CYB003, Dr. Mahableshwarkar’s deep experience of successfully running global phase 3 programs will be invaluable. His broad expertise across strategic, developmental and regulatory domains will no doubt contribute to accelerating Cybin’s path forward.”

To view the full press release, visit https://ibn.fm/83b5y

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For company updates and to learn more about Cybin, visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is scheduled to present at the 72nd Emerging Growth Conference, hosted by leading independent small cap media portal EmergingGrowth.com. Taking place on June 12 – 13, 2024, the event identifies companies in a wide range of growth sectors with strong management teams, innovative products and services, focused strategy, execution, and the overall potential for long-term growth. Joel L. Fruendt, president, CEO and director of SenesTech is scheduled to provide a keynote speech at the conference starting at 3:20 p.m. ET on June 12.

To view the full press release, visit https://ibn.fm/RTAKN

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. It invented ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, and Evolve(TM), an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information about the company, visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements (“REEs”) and vanadium, today announced that it has achieved commercial production of separated neodymium-praseodymium (“NdPr”) at its White Mesa Mill in Utah. According to the announcement, the NdPr produced by Energy Fuels meets applicable product specifications of REE metal makers who specialize in the manufacture of REE-based alloys required for the permanent magnets widely used for electric motors in both battery powered electric vehicles (“EVs”) and dual power hybrids. Further, Energy Fuels is now able to produce this “on-spec” NdPr at the full design capacity of its new phase 1 REE separation circuit (850 to 1,000 metric tons “tonnes” of NdPr per year). The company expects to have commercial quantities of separated NdPr available for shipment by the end of this month. Energy Fuels believes this is the first time in several decades that a U.S. company has produced on-spec separated REE from monazite on a commercial scale.

To view the full press release, visit https://ibn.fm/rpEXq

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium and critical minerals company. The company, as a leading producer of uranium in the United States, mines uranium and produces natural uranium concentrates that are sold to major nuclear utilities for the production of carbon-free nuclear energy. Energy Fuels recently began production of advanced rare earth element (“REE”) materials, including mixed REE carbonate in 2021, and commenced production of commercial quantities of separated REEs in 2024. Energy Fuels also produces vanadium from certain of its projects, as market conditions warrant, and is evaluating the recovery of radionuclides needed for emerging cancer treatments. Its corporate offices are in Lakewood, Colorado, near Denver, and substantially all its assets and employees are in the United States. Energy Fuels holds two of America’s key uranium production centers: the White Mesa Mill in Utah and the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant, as well as REE products, from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The company recently acquired the Bahia Project in Brazil and entered into a joint venture agreement to develop the Donald Project in Australia , each of which is believed to have significant quantities of titanium (ilmenite and rutile), zirconium (zircon) and REE (monazite) minerals. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101-compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects in production, on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol UUUU, and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol EFR. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU  

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Dalmore Group, a tech-driven investment bank and broker dealer on a mission to revolutionize the way companies raise capital online, is spotlighted in the most recent episode of The Bell2Bell Podcast. Released by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, the Bell2Bell Podcast delivers exclusive interviews with executives and professionals operating in fast-moving industries. During the podcast, Dalmore Group director of sales Stormer Santana and host Jonathan Keim discussed what Santana enjoys most about working in online fundraising, which is the opportunity to interact with hundreds of passionate entrepreneurs. Santana also explained how companies raise capital online in the current environment, which started through the JOBS Act, which introduced Regulation Crowdfunding (Reg CF), Regulation A+ and Regulation D. Typically, the general population doesn’t have access to private investment opportunities, Santana observed, but now issuers are leveraging these tools to reach out “the masses, raise capital in volume from the crowd and really bring on a sense of community.” Santana also noted that Reg A+, which allows an entity to raise up to $75 million in capital, is Dalmore’s focus. “We’ve been fortunate enough to participate with some of the really significant offerings in the U.S. and over 50% of all Reg A+ filings, per KingsCrowd,” said Dalmore Group director of sales Stormer Santana in the press release. “Finally, there’s Reg D, which is reserved for accredited investors only. Of course, that’s a very popular and common path to raise capital. Some of our issuers are leveraging CF, A+ and D concurrently in different strategies. At a high level, those are some of the exemptions that we’re focused on and how issuers are leveraging them.”

To listen to the full episode, visit https://ibn.fm/eZPJN

To view the full press release, visit https://ibn.fm/UJ5vW

About Dalmore Group

Dalmore is a tech-driven, FINRA-registered, full-service, broker-dealer on a mission to revolutionize the way companies raise capital online. With its focus on relationships and results, Dalmore is a people-driven firm. Dalmore prides itself on hiring and teaming with professionals that bring integrity, quality and professionalism to its organization so that, through teamwork and a common vision, Dalmore can best serve its clients. For more information, visit the company’s website at www.DalmoreGroup.com

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• ECGI is implementing several prudent measures to create a stronger foundation for pursuing new strategic ventures and growth opportunities
• The company recently announced an agreement to convert $2 million of debt into equity, with conversion expected to be completed during Q4 of its fiscal year
• ECGI has previously announced the reduction of over $1.5 million in liabilities, a reduction of over $350,000 in convertible notes payable and accrued interest, and an improvement in total stockholders’ deficit totaling over $1 million
• The company is determined to position itself to aggressively identify and capitalize on growth opportunities that align with its business objectives

ECGI Holdings (OTC: ECGI), a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion, recently announced an agreement to convert $2 million of debt into equity. The agreement, anchored in section 3(a)(10) of the Securities Act of 1933, is a significant milestone in the company’s ongoing efforts to enhance financial stability in pursuit of significant market opportunities. The debt-to-equity conversion is set to be completed during the ECGI’s fiscal fourth quarter, ending August 31, 2024 (https://ibn.fm/kTWFt).

The 3(a)(10) debt-to-equity conversion is to strengthen the company’s balance sheet, alleviating a significant portion of its financial obligations, and allowing it to redirect its resources toward growth and innovation. During the first two quarters of fiscal 2024, ECGI implemented a number of strategies to reduce the strain of past debts.

The company recently reported successfully identifying and reducing over $1.5 million in accounts payable and accrued liabilities. ECGI heralded this achievement as a testament to its ongoing commitment to operational efficiency and fiscal responsibility. With the significant reduction in its liabilities and the ongoing cleanup of its balance sheet, a March 2024 news release said, the company anticipates a notably positive effect on its share structure.

In addition, ECGI identified and implemented the reduction of more than $350,000 in convertible notes payable and accrued. The company also reported an improvement in the total stockholders’ deficit, amounting to over $1 million. ECGI believes these recent measures to reduce liabilities will contribute significantly to long-term shareholder value as well as the company’s overall economic vitality.

“By reducing the strain of past debts, we are creating a firmer foundation for pursuing new strategic ventures and growth opportunities,” ECGI said in its news release announcing the debt-to-equity conversion. “We expect these financial maneuvers to bolster investor confidence and attract further investments, enhancing shareholder value and solidifying our market position.”

ECGI’s extended commitment to financial health, intended to help unlock future growth potential, is supported operationally by its ongoing focus on growth opportunities that align with its business opportunities. This focus has led to the company investing in Pacific Saddlery, Inc., a premier manufacturer and retailer of luxury products and services. Pacific Saddlery debuted a new mobile retail boutique at the prestigious Desert International Horse Park’s Desert Circuit event earlier this year. The mobile boutique concept enabled ECGI and Pacific Saddlery to take their luxury equestrian products closer to professionals and enthusiasts.

In addition to its strategic investment in Pacific Saddlery, ECGI owns and manages a five-acre vineyard in Lake County, California. The vineyard specializes in the cultivation of Petite Sirah, a variety of grapes famed for its bold and rich character. Besides aligning with the growing demand for unique and high-quality wine experiences, the vineyard enables ECGI to tap into the U.S. wine market, expected to grow from $60.1 billion in 2024 to $73.4 billion by 2028, according to Statista (https://ibn.fm/rA0a1).

ECGI is also eyeing the U.S. segment of the global short-term rental market. The global market is projected to grow at a CAGR of 10.87% from 2024 to 2033, reaching $315.18 billion by the end of the forecast period from $112.31 billion in 2023 (https://ibn.fm/bI0hr). To capitalize on this expected growth, ECGI is transforming its 40-acre Lake County, California, property into a luxurious short-term rental destination known as Vintner’s Caldera Ranch. The program was launched in early May (https://ibn.fm/mp9vO), and includes exposure in Airbnb, Vrbo, and Bookings.com. Evolve will continue to leverage its expertise in maximizing rental potential and delivering exceptional guest experiences to ensure that Vintner’s Caldera Ranch exceeds the high standards of service and luxury that guests expect.

For more information, visit the company’s website at www.ECGIHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines, will be presenting at the Emerging Growth Virtual Conference this week. The two-day event is scheduled for June 12–13, 2024. Longeveron’s presentation is slated to begin at 1:45 p.m. ET on Wednesday, June 12. According to the announcement, anyone interested can view the presentation on the company’s website at that time. In addition, an archived version of the presentation will be available on the company website following the conference; the presentation will be available for approximately six months.

To view the presentation, visit https://ibn.fm/Xzkfb

To view the full press release, visit https://ibn.fm/tzeYQ

About Longeveron Inc. 

Longeveron is a clinical-stage, biotechnology company developing regenerative medicines to address unmet medical needs. The company’s lead investigational product is Lomecel-B(TM), an allogeneic medicinal signaling cell (“MSC”) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B(TM) has multiple potential mechanisms of action encompassing provascular, proregenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty. To learn more about the company, visit www.Longeveron.com.

NOTE TO INVESTORS: The latest news and updates relating to LGVN are available in the company’s newsroom at https://ibn.fm/LGVN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SenesTech (NASDAQ: SNES) is a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats. The company has been rapidly growing with its unique solutions, defined by its two main offerings – ContraPest(R) liquid and Evolve(TM) Soft Bait, both of which have demonstrated impressive results in controlling pest populations through fertility control. “The city of New York is exploring the use of Evolve, owing to its shelf life, safety profile and overall effectiveness… With the introduction of a new bill by an Upper West Side Council Member, the city is set to, hopefully once and for all, deal with the rat menace that has posed a challenge for every generation of New Yorkers,” a recent article reads. “SenesTech is optimistic that its Evolve Soft Bait will yield impressive results, highlighting the product’s overall efficacy while stamping the company’s position as a leader in its space. Already, the company has seen major interest in its Evolve product, and this move by the city of New York is seen as affirming the product’s superiority while serving as a sign of even bigger things to come.”

To view the full article, visit https://ibn.fm/73AtB

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is an expert in fertility control to manage animal pest populations. It invented ContraPest(R), the only U.S. EPA-registered contraceptive for male and female rats, and Evolve(TM), an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable. For more information about the company, visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Life360 (NASDAQ: LIF), a San Francisco-based tracking app company, was featured in a recent Fox Business article. The article highlighted the company’s debut as a public company, noting that Life360 made its initial public offering at $27 per share on Thursday, June 6, with co-founder and CEO Chris Hulls ringing the opening bell. The company now trades on the Nasdaq under the ticker LIF. According to the article, Life360’s popular eponymous app allows family members to track each other’s whereabouts and has around 66 million active users globally. Life360 also owns Jiobit, a tracking device for kids, elderly loved ones and pets, and Tile, a suite of products for tracking devices. The article noted that Life360 is now among the top five social networking apps in the U.S. and has a significant free user base. Life360 nonetheless believes it has only scratched the surface in terms of market penetration. Last year, the company reported $304.5 million in revenue, a year-over-year increase of 33%. Its subscription revenue increased 44% year over year.

To view the full article, visit https://ibn.fm/voYKj

About Life360, Inc.

Life360, a family connection and safety company, keeps people close to the ones they love. The category leading mobile app and Tile tracking devices empower members to stay connected to the people, pets and things they care about most, with a wide range of services, including location sharing, safe driver reports, and crash detection with emergency dispatch. Life360 delivers peace of mind and enhances everyday family life in all the moments that matter, big and small. For more information about the company, visit www.Life360.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• American-based SenesTech, rodent fertility control product provider, growing rapidly with its highly successful and unmatched rodent control technology, is now expanding from government and business markets to the direct consumer market with the launch of its dedicated online store on Amazon
• This brings SenesTech and its products closer to consumers in what its management notes will help drive growth in its fertility solutions for many years to come, and carving out a significant market share in an industry that currently posts over $1 billion in sales annually
• Amazon’s addition follows SenesTech’s recent multiple overseas distribution deals which opened it up to Europe, New Zealand, Australia, and Singapore

SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the launch of its dedicated online store on Amazon. As the world’s largest online retailer, this move brings SenesTech and its products closer to consumers, marking a significant step forward in distributing its flagship Evolve(TM) soft bait (https://ibn.fm/cJrCf). 

According to Joel Fruendt, the company’s CEO, this launch positions SenesTech to revolutionize how everyday consumers safely and proactively combat rodent pests, particularly when regulations are putting more restrictions on applying commonly used poisons. It also marks a significant milestone for the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN